A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status

por Jeung, H-C, Rha, S Y, Shin, S J, Ahn, J B, Noh, S H, Roh, J K, Chung, H C
Publicado 2007

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk

por Cheng, I, Liu, X, Plummer, S J, Krumroy, L M, Casey, G, Witte, J S
Publicado 2007

High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis

por Weichert, W, Boehm, M, Gekeler, V, Bahra, M, Langrehr, J, Neuhaus, P, Denkert, C, Imre, G, Weller, C, Hofmann, H-P, Niesporek, S, Jacob, J, Dietel, M, Scheidereit, C, Kristiansen, G
Publicado 2007

The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcino...

por El-Khoury, V, Breuzard, G, Fourré, N, Dufer, J
Publicado 2007

NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas

por Górka, B, Skubis-Zegadło, J, Mikula, M, Bardadin, K, Paliczka, E, Czarnocka, B
Publicado 2007

Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival

por Pitkin, L, Luangdilok, S, Corbishley, C, Wilson, P O G, Dalton, P, Bray, D, Mady, S, Williamson, P, Odutoye, T, Rhys Evans, P, Syrigos, K N, Nutting, C M, Barbachano, Y, Eccles, S, Harrington, K J
Publicado 2007

MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden

por Andrén, O, Fall, K, Andersson, S-O, Rubin, M A, Bismar, T A, Karlsson, M, Johansson, J-E, Mucci, L A
Publicado 2007

Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo

por Mellor, P, Harvey, J R, Murphy, K J, Pye, D, O'Boyle, G, Lennard, T W J, Kirby, J A, Ali, S
Publicado 2007

Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts

por Vlahovic, G, Ponce, A M, Rabbani, Z, Salahuddin, F K, Zgonjanin, L, Spasojevic, I, Vujaskovic, Z, Dewhirst, M W
Publicado 2007

Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer

por Torrisi, R, Bagnardi, V, Pruneri, G, Ghisini, R, Bottiglieri, L, Magni, E, Veronesi, P, D'Alessandro, C, Luini, A, Dellapasqua, S, Viale, G, Goldhirsch, A, Colleoni, M
Publicado 2007

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer

por Agalliu, I, Karlins, E, Kwon, E M, Iwasaki, L M, Diamond, A, Ostrander, E A, Stanford, J L
Publicado 2007

Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences

por Pieterse, A H, Stiggelbout, A M, Baas-Thijssen, M C M, van de Velde, C J H, Marijnen, C A M
Publicado 2007

Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients

por Hurst, N G, Stocken, D D, Wilson, S, Keh, C, Wakelam, M J O, Ismail, T
Publicado 2007

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial

por Boige, V, Raoul, J-L, Pignon, J-P, Bouché, O, Blanc, J-F, Dahan, L, Jouve, J-L, Dupouy, N, Ducreux, M
Publicado 2007

Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer

por Nonomura, N, Takayama, H, Nishimura, K, Oka, D, Nakai, Y, Shiba, M, Tsujimura, A, Nakayama, M, Aozasa, K, Okuyama, A
Publicado 2007

Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer

por Cheng, Y Y, Yu, J, Wong, Y P, Man, E P S, To, K F, Jin, V X, Li, J, Tao, Q, Sung, J J Y, Chan, F K L, Leung, W K
Publicado 2007

ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein

por Mi, Y, Lou, L
Publicado 2007

Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel

por Martinelli, M, Bonezzi, K, Riccardi, E, Kuhn, E, Frapolli, R, Zucchetti, M, Ryan, A J, Taraboletti, G, Giavazzi, R
Publicado 2007

Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse

por González, L O, Pidal, I, Junquera, S, Corte, M D, Vázquez, J, Rodríguez, J C, Lamelas, M L, Merino, A M, García-Muñiz, J L, Vizoso, F J
Publicado 2007

Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia

por Lee, C-Y, Tien, H-F, Hu, C-Y, Chou, W-C, Lin, L-I
Publicado 2007